Abstract
Postresection villus hyperplasia is a major compensatory mechanism in the short-bowel patient. Substances capable of augmenting postresection mucosal hyperplasia could have therapeutic implications. Human growth hormone (hGH) and human growth hormone releasing factor (hGHRF) stimulate growth of the gastrointestinal tract; however, the diabetogenic actions of growth hormone limit its usefulness in clinical practice. Plerocercoid larvae of the tapewormSpirometra mansonoides produce an analog of hGH void of diabetogenic side effects. We assessed effects of plerocercoid growth factor (PGF) on mucosal adaptation following 70% proximal jejunoileal resection in young rats. Mucosal weight, DNA, protein, and total sucrase activity per centimeter of bowel were increased in resected PGF-treated animals compared to resected controls. We conclude PGF augments intrinsic postresection mucosal hyperplasia following extensive intestinal resection.
Similar content being viewed by others
References
Tilson DM: Pathophysiology and treatment of short bowel syndrome. Surg Clin North Am 60:1273–1284, 1980
Feldman EJ, Dowling RH, MacNaughton J: Effect of oral versus intravenous nutrition on intestinal adaptation after small bowel resection. Gastroenterology 70:712–719, 1976
Vanderhoof JA, Grandjean CJ, Kaufman SS, Burkley KT, Antonson DL: Effect of high percentage medium chain triglyceride on mucosal adaptation following massive small bowel resection in rats. JPEN 8(6):685–689, 1984
Williams CN, Dickson RC: Cholestyramine and medium chain triglycerides in prolonged management of patients subjected to ileal resection or bypass. Can Med Assoc J 107:626–631, 1972
Tandon RK, Rodgers JB, Balint JA: The effects of medium chain triglyceride in the short bowel syndrome. Increased glucose and water transport. Am J Dig Dis 17:233–238, 1972
Zurser RB, Campbell RG, Hashima SA, VanItallie TB: Use of medium chain triglyceride in the management of patients with massive resection of the small intestine. N Engl J Med 274:490–493, 1966
Bohane TD, Hakao-Ikse D, Biggar WD, Hamilton JR, Gall DG: A clinical study of young infants after small intestinal resection. J Pediatr 94:552–558, 1979
Williamson RCN: Intestinal adaptation. N Engl J Med 298(25):1393–1402, 1978
LeBlond CP, Carriere R: The effect of growth hormone and thyroxine on the mitotic rate of the intestinal mucosa of the rat. Endocrinology 56:261–266, 1955
Taylor B, Murphy GM, Dowling RH: Effect of food intake and the pituitary on intestinal structure and function after small bowel resection in the rat. Gut 16:397, 1975
Lehy T, Accary JP, Dubrasquet M, Lewin MJM: Growth hormone-releasing factor (somatocrinin) stimulates epithelial cell proliferation in the rat digestive tract. Gastroenterology 90(3):646–653, 1986
Hintz RL: Biological actions in humans of recombinant DNA synthesized human growth hormone.In Recombinant DNA Products: Insulin, Interferon, and Growth Hormone. AP Bollon (ed). Boca Raton, Florida, CRC Press, 1984
Mueller JF: The biology ofSpirometra. J Parasitol 60:3, 1974
Phares CK, Ruegamer WR: Pigeon crop sac stimulation due to a factor produced by plerocercoids of the tapewormSpirometra mansonoides. Proc Soc Exp Biol Med 143:147, 1973
Phares CK, Ruegamer WR: Effects of the growth factor from the tapeworm,Spirometra mansonoides, on a hypophysectomized rhesus monkey. Proceedings, 58th Endocrine Society Meeting, June 1976
Tsushima T, Friesen H, Chang TW, Raben MS: Identification of sparganum growth factor by a radioreceptor assay for growth hormone. Biochem Biophys Res Commun 59:1062, 1974
Watts DJ, Phares CK: The growth hormone-like factor produced by the tapeworm,Spirometra mansonoides, displaces human growth hormone and its receptors on cultured human lymphocytes. Fed Proc 45(3):997, 1986
Phares CK, Booth BJM: Monoclonal antibodies to human growth hormone and human chorionic somatomamotropin specifically bind the growth hormone-like factor produced by plerocercoids of the tapeworm,Spirometra mansonoides. Fed Proc 44(3):430, 1985
Phares CK: The lipogenic effect of the growth factor produced by plerocercoids of the tapewormSpirometra mansonoides is not the result of hypothyroidism. J Parasitol 68(6):999, 1982
Steelman SL, Mueller JF, Glitzer M, Ostlind D: Biological properties of a growth hormone-like factor from the plerocercoid ofSpirometra mansonoides. Recent Prog Horm Res 27:97, 1977
Phares CK, Salem MAM: The human growth hormone analog produced by the tapewormSpirometra mansonoides is not diabetogenic in the obese (ob/ob) mouse. 68th Annual Endocrine Society Meeting, June 1986 (#749)
Kostyo JL, Gennick SE, Suder SE: Diabetogenic activity of native and biosynthetic human growth hormone in the obese (ob/ob) mouse. Am J Physiol 246:E356, 1984
Cameron CM, Kostyo JL, Papkoff H: Nonmammalian growth hormones have diabetogenic and insulin-like activities. Endocrinology 116:1501, 1985
Lowry OH, Rosebrough NJ, Farr AL, Randall RJ: Protein measurement with the Folin phenol reagent. J Biol Chem 62:265–275, 1951
Schmidt G, Thannhauser SJ: A method for the determination of deoxyribonucleic acid, ribonucleic acid, and phosphoproteins in animal tissue. J Biol Chem 161:83–89, 1945
Munro HN, Fleck A: Methods Biochem Anal 14:173–176, 1966
Burton K: A study of the conditions and mechanism of the diphenylamine reaction for the colorimetric estimation of deoxyribonucleic acid. Biochem J 62:315–323, 1956
Giles KW, Myers A: Improved diphenylamine method for estimation of DNA. Nature 206:93, 1965
Dahlqvist A: Method for assay fo intestinal disaccharidases. Anal Biochem 7:18–25, 1964
Weser E, Henandez MH: Studies of small bowel adaptation after intestinal resection in the rat. Gastroenterology 60:69–75, 1971
Dowling RH: The influence of luminal nutrition on intestinal adaptation after small bowel resection and bypass.In Intestinal Adaptation. RH Dowling, EO Riecken (eds). Stuttgart, Schattauer Verlag, 1974, pp 35–46
Bury KD: Carbohydrate digestion and absorption after massive resection of the small intestine. Surg Gynecol Obstet 135:177–187, 1972
Steel RGD, Torrie JH: Principles and Procedures of Statistics, 2nd ed., New York, McGraw-Hill, 1980
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hart, M.H., Phares, C.K., Erdman, S.H. et al. Augmentation of postresection mucosal hyperplasia by plerocercoid growth factor (PGF). Digest Dis Sci 32, 1275–1280 (1987). https://doi.org/10.1007/BF01296378
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01296378